Radiopharm Theranostics Limited (RADX)

NASDAQ: RADX · Real-Time Price · USD

1.520

-0.490 (-24.38%)

At close: Sep 15, 2026, 4:00 PM EDT

1.575

+0.055 (3.63%)

After-hours: Sep 15, 2026, 7:48 PM EDT

Radiopharm Theranostics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Revenue	2.77	3.63	0.3	0.29	-
Other Revenue	10.73	8.88	1.66	5.92	-
Revenue	13.5	12.51	1.96	6.21	-
Revenue Growth	7.91%	538.86%	-68.46%	-	-
Cost of Revenue	2.5	31.11	21.61	19.53	7.49
Gross Profit	11	-18.6	-19.65	-13.32	-7.49
Selling, General & Admin	16.22	14.64	13.04	12.23	7.64
Research & Development	44.7	-	-	-	-
Operating Expenses	63.32	16.53	15.68	15.27	12.44
Operating Income	-52.32	-35.13	-35.33	-28.59	-19.93
Interest Expense	-0.11	-0.07	-0.64	-0.09	-9.35
Interest & Investment Income	-	0.89	0.05	0.15	0.01
Currency Exchange Gain (Loss)	-	0.14	0.09	-0.26	-1.11
Other Non Operating Income (Expenses)	-0.87	-	-	-	-
EBT Excluding Unusual Items	-53.3	-34.17	-35.83	-28.79	-30.38
Gain (Loss) on Sale of Assets	-	-	-1.69	-	-
Asset Writedown	-5.27	-	-1.48	-3.1	-
Other Unusual Items	1.67	-4.07	-8.86	-2.68	-
Pretax Income	-56.9	-38.24	-47.85	-34.57	-30.38
Income Tax Expense	0.05	0.1	0.1	0.04	0.04
Earnings From Continuing Operations	-56.95	-38.34	-47.95	-34.61	-30.42
Minority Interest in Earnings	1.8	-	-	-	-
Net Income	-55.15	-38.34	-47.95	-34.61	-30.42
Net Income to Common	-55.15	-38.34	-47.95	-34.61	-30.42
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	3,081	2,081	386	306	181
Shares Outstanding (Diluted)	3,081	2,081	386	306	181
Shares Change	48.05%	438.49%	26.36%	68.74%	-
EPS (Basic)	-0.02	-0.02	-0.12	-0.11	-0.17
EPS (Diluted)	-0.02	-0.02	-0.12	-0.11	-0.17
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-52.78	-36.65	-22.98	-23.25	-9.91
Free Cash Flow Per Share	-0.02	-0.02	-0.06	-0.08	-0.06
Gross Margin	81.45%	-148.63%	-	-214.52%	-
Operating Margin	-387.49%	-280.77%	-1803.82%	-460.41%	-
Profit Margin	-408.44%	-306.44%	-2448.23%	-557.36%	-
Free Cash Flow Margin	-390.92%	-292.88%	-1173.12%	-374.36%	-
EBITDA	-49.61	-32.53	-32.2	-25.29	-16.94
EBITDA Margin	-	-260.03%	-	-	-
D&A For EBITDA	2.71	2.6	3.13	3.3	2.98
EBIT	-52.32	-35.13	-35.33	-28.59	-19.93
EBIT Margin	-	-280.77%	-	-	-

SEC Filings: 10-K · 10-Q